U1
Binds to the 5’ splice site (initial)
U2
Binds to the branch point site and adenosine bulges out
Adenosine in splicing
Attacks 5’ splice site, which catalyzes the 3’OH on 5’ to attack the 3’ splice site.
Nuclear pore complex
Saves unimpaired mRNA from their default fate of degradation. Moves mRNA into cytoplasm away from exonuclease.
Pre-mRNA
Has RNA pol, guanyl transferase, poly(A) polymerase, and U1 snRNP.
Larger rRNAs
Made up by RNA pol 1
Catalyzes bond between amino acids
Smaller rRNAs
Made by RNA pol 3
Interacts with anticodon
Pre-rRNA
methylated, cleaved. Modified (isomerization) (uridine → pseudouridine)
Wobble base pairing
U → A or G
G → A or C
I → U, A, or C
tRNA
Binded to tryptophan, has a proofreading function.
Amino acid is added to polypeptide c-terminal
Functional domains
Independent, different proteins make same domain, domains can be used in different cells, multiple domains can be made by one protein.
IF1
attaches to mRNA in prokaryotic initiation
IF2
GTP-binding protein and attaches to first amino acid in prokaryotic initiation
IF3
Prevents premature attachment of large subunit
eIF1 / 1A
Binds to mRNA and changes confirmation in eukaryotic initiation
eIF3
Interacts with eIF4G
eIF4E
Binds to 5’ cap in eukaryotic initiation
eIF4A
Helicase properties, uses ATP hydrolysis to unwind ds mRNA in eukaryotic initiation
EF-Tu
Accuracy check of the transcription elongation factors
Binds to codon-anticodon, correct pairing will trigger conformational change.
Transcription factors
A single gene can be regulated by multiple, it can be involved in regulating multiple genes, it’s role differs in different contexts
Enhancer sequences
Studied by GFP, deletion mapping, and reporter gene fusion
Eukaryotes regulate
With positive and negative feedback
Prokaryotes regulate
With tryptophan repressor (binds to operon when tryptophan is present) and Lac operon.
Post-transcriptional regulation
Alternative splicing, editing issues, alternate cleavage and polyadenylation, mRNA regulation
Exonic splice enhancer/suppressor
Controls how often an exon is included or excluded
UTR
mRNA stability, translation and localization, and degradation
RNAi
Small manipulated RNA pieces regulate eukaryotic genes. ssRNA, RISC complex, miRNA, siRNA.
Yamanaka factors
Cell → pluripotent cells (induced pluripotent seme cells)
Morphogens
Guides phenotype and development of cell fate (concentration dependent of cell signaling) (signaling factors)
Src mutations
Tyr 527 → loses inhibitory interaction
SH3 → loses inhibitory interaction
Overabundance of Tyr
Nonsense after C-terminal (pY)
Angiogenesis
Making tumour blood supply
Growth factors
Promotes tumours, up and downstream
Signaling factors that stimulate cellular processes like survival, growth, repair and differentiation. Paracrine.
RTK
Promotes tumours, upstream and downstream.
Part of enzyme coupled reactions (Epidermal growth factor receptor). Helps stuff grow. Helps receptor function and tyrosine kinase activity.
Ras GTPase
Promotes tumours, upstream
Drives growth, proliferation and migration of cells when active (GTP form). Activated by GEFs.
PI3K
Promotes tumours downstream.
Converts PIP2 → PIP3, which recruits Akt.
Akt
Promotes tumours downstream.
Serine/threonine kinase that binds to PIP3, influences proliferation and cell metabolism.
Src
Promotes upstream
Viral oncogene, helped discover lots to do with cancer.
PTEN
Inhibits tumours downstream
Loss of this phosphatase increases Akt signaling in cancer cells.
MAPK
Promotes and inhibits tumours downstream
Scaffold protein mediated, promotes proliferation, active downstream of Ras.
Cancer promotion
Genomic instability, cell division, heterogeneity, driver mutation
snoRNA
Processes rRNA for rDNA
2D gel electrophoresis
Separates proteins by mass and charge to create an array of dots that reflect proteome of the cell type analyzed
Exon shuffling
What creates new combos of protein domains, as opposed to alternative splicing.
miRNA
Likely evolved from siRNA viral defense mechanism
CRISPR
Discovered by short repetitive sequences in prokaryotic genomes, HR pair creates specific changes in genome, involves crRNA direction a nuclease to cleave.
Master regulator
A transcription factor with a key role in directing cell fate
GCPR
Function as GEFs when activated. All contain a serine/threonine kinase domain domain.
Secondary Messengers
Direct connection between signalling molecules (neurotransmitter, growth)
HDAC
Recruited by Rb, promotes more closed chromatin confirmation. Rb is a tumour suppressor
R point
Until this, Rb is bound to E2F. It occurs in G1 and regulates progression into S-phase. Many growth promoting and growth inhibiting pathways converge on regulating this.
MDM2
Is more likely to be polyubiquitinated p53 in untreated non-stressed cells.
Increase protein
Gene amplification, loss of the 3’ UTR miRNA, kinase domain missense mutation, frame fusion of kinase
snRNA
In splicing, this base pairs with 5’ splice site, 3’ splice site and a branch point in the intron.
Situ hybridization
mRNA detected through base pairing with probe. Confirm specific sequence is in one area (elongation helper)
RNA sequencing
All mRNA is analyzed. Find genes that differ. What is highly transcribed.
Fragment RNA → Reverse transcription → PCR → Sequence
Operon
A secondary messenger informs of status. Each contains regulatory DNA sequences, promote or inhibit transcription.
mRNA localization
Sequences in the 5’/3’ UTR come into contact with things and they either anchor, protect or transport in local area. One stays stem cell, one differentiates.
lncRNA
Can bind complementary sequences and recruit proteins to act on those genes. Complementary base pair to target particular RNA or DNA. Regulation using non-coding RNA.
RISC complex
1 strand is degraded, leaving miRNA. Argonaute proteins in it are the key.
crRNA
CRISPR used this as a small non-coding RNA molecule to seek & destroy invading viral genomes (complementary base pair and target nuclease digestion)
Tyrosine kinase
Is autoinhibited. Whole complex turned off until growth is activated. Maximally ready to go when Tyr416 is phosphorylated.
Truncanation
Tumour virus helped to identify one of the oncogenic mechanisms of activation. Cytoplasmic domains join and are mimicked. Removes extracellular domain, leading to cancer.
Tumour microenvironment
The surrounding network of ECM, signaling molecules, immune cells, fibroblasts, blood vessels, and resident normal tissue. Tumour stroma.